Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 443-445

  Kristie Johnson, J ^a   Wilson, Lucy E ^b   Zhao, LiCheng ^a   Richards, Katherine ^b   Thom, Kerri A ^a   Harris, Anthony D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM CULTURE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; GENE AMPLIFICATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HUMAN; KLEBSIELLA PNEUMONIAE CARBAPENEM PRODUCING ENTEROBACTERIACEAE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NOTE; PREVALENCE; BIOSYNTHESIS; ENZYMOLOGY; EPIDEMIOLOGY; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; UNITED STATES;

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; HOSPITALIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MARYLAND; PREVALENCE; RESPIRATION, ARTIFICIAL;

EID: 84895793271     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675610     Document Type: Note

References (10)

1. Landman D, Babu E, Shah N, et al. Transmission of carbapenemresistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother 2012;67(6):1427-1431.
2. Gupta, N, Limabago B, Patel J, Kallen A. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53(1):60-67.
3. Queenan AB, Karen. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20(3):440-458.
4. Patel G, Huprikar S, Factor S, Jenkins S, Calfee D. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099-1106.
5. Thom KA, Maragakis LL, Richards K, et al. Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. Infect Control Hosp Epidemiol 2012;33(9):883-888.
6. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29(10):966-968.
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Testing, Twenty-Second Informational Supplement. M100-S22. Wayne, PA: CLSI, 2012.
8. Rasheed JK, Biddle JW, Anderson KF, et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenemhydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 2008;46(6):2066-2069.
9. Jacob JT, Klein E, Laxminarayan R, et al. Vital signs: carbapenem-resistant Enterobacteriaceae. Morb MortalWeekly Rep 2013; 62(9):165-170.
10. Thibodeau E, Duncan R, Snydman DR, et al. Carbapenemresistant enterobacteriaceae: a statewide survey of detection in Massachusetts hospitals. Infect Control Hosp Epidemiol 2012; 33(9):954-956.